Current Cancer Drug Targets

Editor-in-Chief

Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
(USA)

Personal Subscription
Become EABM
Become Reviewer

Volume 21 - Issue 1



Preface promotion: free to download

Volume: 21   Issue: 1
Pp: 1-1
Ruiwen Zhang
DOI: 10.2174/156800962101210114094950



C-Myc Signaling Pathway in Treatment and Prevention of Brain Tumors

Volume: 21   Issue: 1
Pp: 2-20
Milad Ashrafizadeh, Ali Zarabi, Kiavash Hushmandi, Ebrahim Rahmani Moghadam, Farid Hashemi, Salman Daneshi, Fardin Hashemi, Shima Tavakol, Reza Mohammadinejad, Masoud Najafi*, Namrata Dudha and Manoj Garg*
DOI: 10.2174/1568009620666201016121005



The Activation of Procarcinogens by CYP1A1/1B1 and Related Chemo-Preventive Agents: A Review

Volume: 21   Issue: 1
Pp: 21-54
Yubei Li, Jiahua Cui and Jinping Jia*
DOI: 10.2174/1568009620666201006143419



Tyrosine Kinase Inhibitors (TKIs) in Lung Cancer Treatment: A Comprehensive Analysis

Volume: 21   Issue: 1
Pp: 55-69
Sivakumar Murugesan, Jayakumar Murugesan, Seedevi Palaniappan , Sivasankar Palaniappan, Tamilselvi Murugan, Shahid S. Siddiqui and Sivakumar Loganathan*
DOI: 10.2174/1568009620666201009130008



Tumor Penetrating Peptide-Functionalized Tenascin-C Antibody for Glioblastoma Targeting

Volume: 21   Issue: 1
Pp: 70-79
Prakash Lingasamy, Anett-Hildegard Laarmann and Tambet Teesalu *
DOI: 10.2174/1568009620666201001112749



ASPM Predicts Poor Clinical Outcome and Promotes Tumorigenesis for Diffuse Large B-cell Lymphoma

Volume: 21   Issue: 1
Pp: 80-89
Jingjing Wu, Zhengmei He, Yaning Zhu, Chao Jiang, Yuan Deng and Bin Wei*
DOI: 10.2174/1568009620666200915090703